KEI statement on the J&J darunavir announcement | Knowledge Ecology International
►http://keionline.org/node/1613
Johnson and Johnson “announced their intention not to enforce the patents they own and control on the antiretroviral (ARV) drug darunavir provided the darunavir product is medically acceptable and is used only in resource-limited settings,” which J&J defines as the 48 UN defined Least Developed Countries plus any other country in sub-Saharan Africa.
une bonne nouvelle mais quand on regarde les détails c’est pas grandiose non plus : J&J n’appliquera pas ses #brevets là où en gros ils ne s’appliquent déjà pas